Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic top the list of 15 drugs selected for the second round of federal price negotiations, which are scheduled to begin this year, with ...
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
Highly coveted weight-loss related diabetes drugs ... be subject to price controls by Medicare. On Friday, the Centers for Medicare & Medicaid Services (CMS) released the second list of ...
Medicare announced Friday that it has selected 15 drugs, including the hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, as well as some blockbuster cancer ...
The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including Ozempic and Wegovy, the drugs at the center of the weight-loss craze.
Under the new deals, list prices were reduced by hundreds — in some cases, thousands — of dollars for 30-day supplies of popular drugs used by millions of people on Medicare. They included ...
The Biden administration, in its last full weekday in office, announced the next 15 drugs up for Medicare price negotiation. Blockbuster diabetes drug Ozempic is on the list. That means the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback